Differences in Breast Cancer Risk Factors According to the Estrogen Receptor Level of the Tumor23
Open Access
- 1 June 1983
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 70 (6) , 1027-1031
- https://doi.org/10.1093/jnci/70.6.1027
Abstract
One hundred and forty-eight postmenopausal breast cancer cases and 585 postmenopausal controls were included in an investigation of whether various risk factors for breast cancer are associated with the level of estrogen (E) receptor (ER) protein in the tumor. In an intracase analysis, the tumor ER level was positively associated with nulliparity, late age at first live birth, a history of benign breast disease, and having breast-fed at least 1 child and was negatively associated with previous use of E replacement therapy. A casecontrol analysis sugges.ted that the first three variables, established risk factors for breast cancer, are associated with an increased risk for malignant breast tumors that are ER-positive but not for those that are ER-negative. This analysis did not provide a clear interpretation of the findings in the intracase comparisons with regard to prior breastfeeding and the use of E replacement therapy.Keywords
This publication has 13 references indexed in Scilit:
- Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathologyCancer, 1981
- Menopausal estrogen use and risk of breast cancerCancer, 1981
- Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patientsBritish Journal of Cancer, 1980
- REPLACEMENT ESTROGENS AND BREAST CANCER1American Journal of Epidemiology, 1980
- Estrogen and progesterone receptors in vaginal and uterine adenocarcinomas following estrogen useGynecologic Oncology, 1980
- A case-control study of menopausal estrogen therapy and breast cancerJAMA, 1980
- A Relationship between Artifical Menopause, Previous Estrogen Consumption, and Estrogen Receptor Content of Breast NeoplasmsOncology, 1980
- ANOVULATION AND INCREASED ANDROGENIC ACTIVITY AS BREAST-CANCER RISK IN WOMEN WITH FIBROCYSTIC DISEASE OF BREAST1978
- Inadequate Corpus Luteal Function in Women with Benign Breast DiseasesJournal of Clinical Endocrinology & Metabolism, 1977
- Menopausal Estrogens and Breast CancerNew England Journal of Medicine, 1976